Live from the NIH registry
Studies recruiting near Cedar Rapids right now
Top 25 of 582 recruiting studies, sorted by proximity — each links to its official registry page
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
Generalized Myasthenia Gravis
N/A
Observational 500 participants sought
Clinical Trial Site — Iowa City, Iowa (22.4 mi)
· Sponsor: Alexion Pharmaceuticals, Inc.
Palbociclib and Pembrolizumab in Sarcoma
Sarcoma
Phase 1
Interventional 8 participants sought
University of Iowa Hospitals & Clinics — Iowa City, Iowa (22.4 mi)
· Sponsor: John Rieth
JUPITER 4.0 - Risk Factors for Failure of Isolated Medial Patellofemoral Ligament Reconstruction
Patellar Dislocation, Recurrent, Patellar Dislocation
N/A
Observational 850 participants sought
University of Iowa — Iowa City, Iowa (22.4 mi)
· Sponsor: Hospital for Special Surgery, New York
Creating Health Course Study for People With Rheumatological Conditions and Mood Disorders
Rheumatoid Arthritis, Sjogren's Syndrome
N/A
Interventional 400 participants sought
Univeristy of Iowa — Iowa City, Iowa (22.4 mi)
· Sponsor: Terry L. Wahls
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Large B-cell Lymphoma, Lymphoma, B-Cell
Phase 3
Interventional 400 participants sought
University of Iowa — Iowa City, Iowa (22.4 mi)
· Sponsor: Lyell Immunopharma, Inc.
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
Advanced Renal Cell Carcinoma (RCC)
Phase 1, Phase 2
Interventional 474 participants sought
University Of Iowa Hospitals And Clinics — Iowa City, Iowa (22.4 mi)
· Sponsor: Bristol-Myers Squibb
A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A
Hemophilia A
Phase 3
Interventional 138 participants sought
University of Iowa Hospitals and Clinics — Iowa City, Iowa (22.4 mi)
· Sponsor: Hoffmann-La Roche
Glaucoma Related Quality of Life
Glaucoma
N/A
Observational 5,000 participants sought
University of Iowa, Dept. of Ophthalmology & Visual Sciences — Iowa City, Iowa (22.4 mi)
· Sponsor: Marc Toeteberg-Harms
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
N/A
Observational 20,000 participants sought
University of Iowa — Iowa City, Iowa (22.4 mi)
· Sponsor: Heart Rhythm Clinical and Research Solutions, LLC
A Study to Evaluate the Safety of AB-1003 (Previously LION-101) in Subjects With Genetic Confirmation of LGMD2I/R9 (Part1)
Limb Girdle Muscular Dystrophy, Limb-Girdle Muscular Dystrophy Type 2
Phase 1, Phase 2
Interventional 10 participants sought
University of Iowa — Iowa City, Iowa (22.4 mi)
· Sponsor: AskBio Inc
The Effects of the CF Carrier State on the Kidneys and Pancreas
Carrier State, Pancreatic Disease
N/A
Observational 1,250 participants sought
University of Iowa Hospitals and Clinics — Iowa City, Iowa (22.4 mi)
· Sponsor: Philip Polgreen
Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer
Recurrent Endometrial Carcinoma, Recurrent Endometrial Clear Cell Adenocarcinoma
Phase 1
Interventional 65 participants sought
University of Iowa/Holden Comprehensive Cancer Center — Iowa City, Iowa (22.4 mi)
· Sponsor: National Cancer Institute (NCI)
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer
Phase 3
Interventional 600 participants sought
University of Iowa — Iowa City, Iowa (22.4 mi)
· Sponsor: Hoffmann-La Roche
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Cystic Fibrosis (CF), Cystic Fibrosis-related Diabetes
N/A
Observational 200 participants sought
University of Iowa — Iowa City, Iowa (22.4 mi)
· Sponsor: Jaeb Center for Health Research
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Prostate Cancer
Phase 3
Interventional 940 participants sought
Univ Of Iowa Hospitals And Clinics — Iowa City, Iowa (22.4 mi)
· Sponsor: Novartis Pharmaceuticals
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Iowa City, Iowa (22.4 mi)
· Sponsor: Sameek Roychowdhury
A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)
Colo-rectal Cancer
Phase 2
Interventional 79 participants sought
University of Iowa - Holden Comprehensive Cancer Center — Iowa City, Iowa (22.4 mi)
· Sponsor: NSABP Foundation Inc
Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
Bladder Cancer, Recurrent Bladder Cancer
N/A
Observational 408 participants sought
University of Iowa — Iowa City, Iowa (22.4 mi)
· Sponsor: University of Washington
Neoadjuvant Weekly Paclitaxel and Biomarkers of Therapy Response
Breast Neoplasm Female
Phase 4
Interventional 50 participants sought
University of Iowa Health Care/Holden Comprehensive Cancer Center — Iowa City, Iowa (22.4 mi)
· Sponsor: University of Wisconsin, Madison
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
Spinal Muscular Atrophy (SMA)
N/A
Observational 700 participants sought
University of Iowa — Iowa City, Iowa (22.4 mi)
· Sponsor: Novartis Pharmaceuticals
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen
Phase 3
Interventional 136 participants sought
University of Iowa Hospitals & Clinics- Holden Comprehensive Cancer Center — Iowa City, Iowa (22.4 mi)
· Sponsor: Servier Bio-Innovation LLC
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Breast Neoplasms, Neoplasm Metastasis
Phase 3
Interventional 800 participants sought
University of Iowa — Iowa City, Iowa (22.4 mi)
· Sponsor: Eli Lilly and Company
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
Multiple Myeloma, Relapsed/Refractory Multiple Myeloma
Phase 2
Interventional 100 participants sought
University of Iowa — Iowa City, Iowa (22.4 mi)
· Sponsor: C4 Therapeutics, Inc.
A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma
Histologically Confirmed Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
Phase 1, Phase 2
Interventional 155 participants sought
University of Iowa Health Care — Iowa City, Iowa (22.4 mi)
· Sponsor: TORL Biotherapeutics, LLC
Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm
NSCLC, Stage I
Phase 2
Interventional 244 participants sought
University of Iowa Hospitals and Clinics — Iowa City, Iowa (22.4 mi)
· Sponsor: Greg Durm, MD